Variation in incidence and survival by ethnicity for patients with myeloma in England (2002-2008).

about

Estimating the prevalence of hematological malignancies and precursor conditions using data from Haematological Malignancy Research Network (HMRN).Next-generation sequencing of a family with a high penetrance of monoclonal gammopathies for the identification of candidate risk alleles.

P2860

Q31111112-E076791F-960B-4103-A7A6-1890A452862E Q38764731-55B33838-BB6C-4AD5-8DF6-FCBF8549451E

P2860

Variation in incidence and survival by ethnicity for patients with myeloma in England (2002-2008).

Item

http://www.wikidata.org/entity/Q41479797

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Variation in incidence and sur ...... yeloma in England (2002-2008).

@en

type

Item

label

Variation in incidence and sur ...... yeloma in England (2002-2008).

@en

prefLabel

Variation in incidence and sur ...... yeloma in England (2002-2008).

@en

P1476

Variation in incidence and sur ...... myeloma in England (2002-2008)

@en

P2093

Edward Bolton

http://www.w3.org/2001/XMLSchema#string

Eva J Morris

http://www.w3.org/2001/XMLSchema#string

James Ross

http://www.w3.org/2001/XMLSchema#string

Steven E Oliver

http://www.w3.org/2001/XMLSchema#string

P2860

Racial differences in the prevalence of monoclonal gammopathy in a community-based sample of the elderly

Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study

The Haematological Malignancy Research Network (HMRN): a new information strategy for population based epidemiology and health service research

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

Lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma: an open-label randomised controlled trial

Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls

Race and outcomes of autologous hematopoietic cell transplantation for multiple myeloma.

Using routinely collected health data to investigate the association between ethnicity and breast cancer incidence and survival: what is the impact of missing data and multiple ethnicities?

Cancer incidence in British Indians and British whites in Leicester, 2001-2006.

Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management.

P304

2660-2667

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/10428194.2014.1003060

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Elizabeth F Samy

P577

2015-03-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25651425

http://www.w3.org/2001/XMLSchema#string

Variation in incidence and survival by ethnicity for patients with myeloma in England (2002-2008).

about

P2860

P2860

Variation in incidence and survival by ethnicity for patients with myeloma in England (2002-2008).

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698